首页> 外国专利> FACTOR IXA: FACTOR VIIIA INTERACTION AND METHODS THEREFOR

FACTOR IXA: FACTOR VIIIA INTERACTION AND METHODS THEREFOR

机译:因子IXA:因子VIIIA相互作用及其方法

摘要

Novel agents that inhibit the interaction of factor VIIIa with factor IXa in newly discovered regions of interaction, Region 2 and Region 3, are disclosed. The novel polypeptides or derivatives of polypeptides prevent activation of factor X and have anti-coagulation activity. The agents include polypeptides or polypeptide derivatives that are homologous to factor VIIIa or factor IXa in Region 2 and/or Region 3, as well as agents that are not homologous, such as antibodies that bind to factor VIIIa or factor IXa in Region 2 or Region 3. Pharmaceutical compositions comprising the agents are also disclosed. Methods of treatment are also disclosed, comprising the step of determining whether the compound displaces the interaction of the above agent from factor VIII or factor IX. Methods for preventing coagulation in a blood sample are also disclosed. These methods comprise adding the above agent to the sample.
机译:公开了在新发现的相互作用区域2和3中抑制因子VIIIa与因子IXa相互作用的新型药物。新的多肽或多肽衍生物防止因子X的活化并具有抗凝血活性。所述试剂包括与区域2和/或区域3中的因子VIIIa或因子IXa同源的多肽或多肽衍生物,以及不同源的试剂,例如与区域2或区域中的因子VIIIa或因子IXa结合的抗体。 3.还公开了包含试剂的药物组合物。还公开了治疗方法,包括确定该化合物是否取代了上述试剂与因子VIII或因子IX的相互作用的步骤。还公开了用于防止血液样品中凝结的方法。这些方法包括将上述试剂添加到样品中。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号